SOMX Financial Facts
Loss from operations: -4.48MBasic and diluted net loss per share: -0.65
See Full Income Statement
Accumulated deficit: -284.92M
Intangibles, net: 940K
See Full Balance Sheet
Somaxon Pharmaceuticals (SOMX) Earnings
|
Expand Research on SOMX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -25.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.4% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/31/12  |
Q312 | -$0.65 | -$0.35 | -$0.30 | $2.1M | $2.3M | N/A |  | | Details | |
| 5/10/12 |
 |
Q112 | -$0.04 | -$0.04 | $0.00 | $2.74M | $3.31M | N/A | | | Details |
| 3/8/12 |
|
Q411 | -$0.21 | -$0.21 | $0.00 | $3.9M | $4.42M | N/A | | | Details |
| 11/3/11 |
|
Q311 | -$0.36 | -$0.31 | -$0.05 | $3.7M | $4.55M | N/A | | | Details |
| 8/2/11 |
|
Q211 | -$0.33 | -$0.36 | +$0.03 | $6.2M | $3.79M | N/A | | | Details |
| 5/3/11 |
|
Q111 | -$0.38 | -$0.35 | -$0.03 | $2.2M | $2.22M | N/A | | | Details |
| 3/3/11 |
|
Q410 | -$0.42 | -$0.40 | -$0.02 | $1.34M | $1.73M | N/A | | | Details |
